Treatment of AIDS Vacuolar Myelopathy With Methionine

Completed · Phase 3

Conditions studied: Myelopathy, AIDS-Myelopathy, AIDS Vacuolar Myelopathy

In brief

The purpose of this study is to determine whether methionine, an amino acid present in low doses in the normal diet, can improve myelopathy or stop its progression.

Key facts

Study ID

NCT00032695

Run by

National Institute of Neurological Disorders and Stroke (NINDS)

People needed

56

Last updated by the study team

2006-05-15

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Beth Israel Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.